ReviewNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Immune dysregulation and epileptogenesis.
Review in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pathogenesis of epilepsy is thought to involve not only electrical imbalances but also autoantibodies, glial cells dysfunctions, cytokine signaling, and disruption of the blood-brain barrier. Autoimmune epilepsy is an immune-mediated neurological disorder caused by dysregulation of the immune system, leading to hyperexcitability of neural networks and epileptogenesis. This paper aimsto review the neuroimmunological mechanisms of autoimmune epilepsy, the processes of epileptogenesis, and modern diagnostic approaches. The role of blood-brain barrier damage, which allows autoantibodies and immune cells to enter the central nervous system, thereby contributing to neuroinflammation and disrupt ing synaptic transmission, is discussed. Particular attention is paid to functional changes in glial cells-astrocytes and microglia-including disruption of glutamate homeostasis, the action of proinflammatory cytokines (IL-1β, TNF-α, IL-6), and complement activation. The paper describes in detail the effects of autoantibodies on neuronal surface antigens, including NMDA, AMPA, and GABA receptors, as well as the LGI1 and CASPR2 complexes. These mechanisms lead to receptor internalization, impaired synaptic plasticity, loss of inhibitory control, and hyperexcitability of the neural network. Particular attention is paid to clinical and biochemical correlations, the phenotypic characteristics of specific autoantibodies, diagnostic challenges in seronegative autoimmune epilepsy, and cerebrospinal fluid markers. Further study of these mechanisms will not only contribute to a better understanding of the disease but also to the development of new antiepileptic and targeted immunotherapeutic strategies.
Indexed as
Identifiers
42820995What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.